Abstract
The search for novel heterocyclic compounds with a natural product skeleton as potent enzyme inhibitors against clinical hits is our prime concern in this study. Here, a simple and facile two-step strategy has been designed to synthesize a series of novel coumarin-based dihydropyranochromenes (12a-12m) in a basic moiety. The synthesized compounds were thus characterized through spectroscopic techniques and screened for inhibition potency against the cytosolic hCA II isoform and beta-glucuronidase. Few of these compounds were potent inhibitors of hCA II and beta-glucuronidase with varying IC50 values ranging from 4.55 +/- 0.22 to 21.77 +/- 3.32 mu M and 440.1 +/- 1.17 to 971.3 +/- 0.05 mu M, respectively. Among the stream of synthesized compounds, 12e and 12i were the most potent inhibitors of beta-glucuronidase, while 12h, 12i, and 12j showed greater potency against hCA II. In silico docking studies illustrated the significance of substituted groups on the pyranochromene skeleton and binding pattern of these highly potent compounds inside enzyme pockets.